Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Short Interest Update

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) was the recipient of a significant decrease in short interest in the month of December. As of December 15th, there was short interest totaling 30,788 shares, a decrease of 33.1% from the November 30th total of 45,995 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 22,913 shares, the short-interest ratio is presently 1.3 days. Based on an average daily trading volume, of 22,913 shares, the short-interest ratio is presently 1.3 days. Currently, 0.1% of the shares of the company are short sold.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Zhengye Biotechnology in a research note on Tuesday, October 14th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Zhengye Biotechnology presently has a consensus rating of “Sell”.

Zhengye Biotechnology Stock Performance

Shares of ZYBT stock opened at $1.20 on Tuesday. Zhengye Biotechnology has a 52 week low of $1.20 and a 52 week high of $14.30. The company has a 50-day simple moving average of $2.10 and a 200 day simple moving average of $4.87. The company has a quick ratio of 1.10, a current ratio of 1.49 and a debt-to-equity ratio of 0.01.

Hedge Funds Weigh In On Zhengye Biotechnology

Institutional investors and hedge funds have recently made changes to their positions in the company. Geode Capital Management LLC bought a new position in shares of Zhengye Biotechnology during the second quarter worth approximately $174,000. Invesco Ltd. bought a new stake in Zhengye Biotechnology in the 2nd quarter valued at $220,000. Jane Street Group LLC acquired a new position in Zhengye Biotechnology in the 2nd quarter valued at $1,158,000. WINTON GROUP Ltd bought a new position in Zhengye Biotechnology during the 3rd quarter worth $56,000. Finally, Citadel Advisors LLC bought a new position in Zhengye Biotechnology during the 3rd quarter worth $31,000.

About Zhengye Biotechnology

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.